CA2487496C - Fluid management system for coronary intervention - Google Patents
Fluid management system for coronary intervention Download PDFInfo
- Publication number
- CA2487496C CA2487496C CA2487496A CA2487496A CA2487496C CA 2487496 C CA2487496 C CA 2487496C CA 2487496 A CA2487496 A CA 2487496A CA 2487496 A CA2487496 A CA 2487496A CA 2487496 C CA2487496 C CA 2487496C
- Authority
- CA
- Canada
- Prior art keywords
- fluid
- injection system
- line
- fitting
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 74
- 238000002347 injection Methods 0.000 claims abstract description 40
- 239000007924 injection Substances 0.000 claims abstract description 40
- 239000002699 waste material Substances 0.000 claims abstract description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 17
- 239000011780 sodium chloride Substances 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 description 10
- 239000002872 contrast media Substances 0.000 description 5
- 238000002583 angiography Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 210000005242 cardiac chamber Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3344—Measuring or controlling pressure at the body treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3362—Pressure; Flow with minimised length of fluid lines; Taking into account the elastic expansion of fluid lines to increase accuracy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
Abstract
A fluid injection system is disclosed. The system is adapted to employ first and second injectors which may sequentially, or simultaneously, inject first and second fluids into a patient via a catheter. The first and second injectors may be power actuated. The actuation of the injectors may be controlled via a controller of the system. The user may be provided with an operator interface module to enable the control of the system to be affected during operation. A separate waste line may be provided to drain the system effectively and efficiently. A pressure sensor may be provided proximate the catheter to reduce pressure signal wave dampening and fluid waste.
Description
PATENT APPLICATION
FLUID MANAGEMENT SYSTEM FOR CORONARY INTERVENTION
FIELD OF THE DISCLOSURE
The disclosure generally relates to fluid dispensing machines and, more particularly, relates to fluid dispensing machines for use with power actuated syringes.
BACKGROUND OF THE DISCLOSURE
During medical procedures, fluids of different types need to be injected into human tissue and vascular structures. One such procedure is known as angiography.
Angiography is a procedure used in the detection and treatment of abnormalities or restrictions in blood vessels, heart chambers and heart valves. During angiography, a radiographic image of a vascular structure is obtained by injecting radiographic contrast material through a catheter into such a vessel, heart chamber, or heart valve.
X-rays are then passed through the region of the body in which the contrast material was injected. The X-rays are absorbed by the contrast material causing a radiographic outline or image of the blood vessel containing the contrast material. The x-ray images of the blood vessels filled with the contrast material are usually recorded on the film or videotape and displayed on a fluoroscope monitor.
The injection of the contrast or other fluids can be performed either manually or automatically. In both procedures, a catheter is inserted into a vessel, which in turn is connected to a fluid line leading to a manifold and in turn to an injector or syringe.
The plunger of the syringe is then either manually or automatically depressed to inject fluid through the fluid line, the catheter, and into the patient.
In certain situations, it is necessary to dilute the concentration of contrast being injected into a patient. For example, in those patients with renal insufficiency incapable of processing concentrated contrast through their system, or in cases where a large amount of contrast is used, such as complicated coronary interventions (PTCA) or peripheral (PTA) cases with runoffs, direct injections of contrasts, are not possible. Accordingly, it is necessary to mix the contrasts and saline prior to injection to arrive at the appropriate dilution percentage. Such processes are necessarily slow and are currently difficult to achieve.
In addition, during injections, it is desirable for the physician or technician to be provided with feedback as to the pressure within the vessel. This is commonly provided by way of a pressure transducer mounted relatively close to the injection apparatus. However, since a relatively long expanse of conduit exists between the catheter and the injector, typically on the order of four feet or more, pressure waveforms must be transmitted through the fluid contained within that conduit all the way from the body of the patient, through the catheter, and back to the pressure transducer. Due to such distances, the waveforms may be substantially dampened by the time they reach the transducer thereby providing an inaccurate or poor signal for display to the physician.
Furthermore, after an injection is made, and it is desired to remove the contrast from the injection system or change the fluid being injected, it is currently necessary to evacuate or aspirate the entire injection line. It would be advantageous if the waste could be quickly removed, while at the same time limiting the total volume of waste fluid encountered by the system.
SUMMARY OF THE DISCLOSURE
In accordance with one aspect of the disclosure, an injection system is provided which comprises a first power actuated injector, a second power actuated injector, a fitting, and a catheter. The first power actuated injector is adapted to inject a first fluid through a first fluid line having a distal end, and the second power actuated injector is adapted to inject a second fluid through a second fluid line having a distal end. The fitting has first and second inputs and an output, with the distal ends of the first and second fluid lines being connected to the first and second inputs of the fitting, respectively. The catheter is connected to the fitting output.
In accordance with another aspect of the disclosure, a method of injecting fluid is provided which comprises the steps of providing a first power actuated injector, providing a second power actuated injector, connecting first and second fluid lines to a single catheter, and actuating one of the first and second power actuated injectors. The first power actuated injector is adapted to transport a first fluid from a first receptacle through the first fluid line, while the second power actuated injector is adapted to transport a second fluid from a second receptacle through the second fluid line.
These and other aspects and features of the disclosure will become more apparent upon reading the following detailed description in conjunction with the accompanying drawings.
FLUID MANAGEMENT SYSTEM FOR CORONARY INTERVENTION
FIELD OF THE DISCLOSURE
The disclosure generally relates to fluid dispensing machines and, more particularly, relates to fluid dispensing machines for use with power actuated syringes.
BACKGROUND OF THE DISCLOSURE
During medical procedures, fluids of different types need to be injected into human tissue and vascular structures. One such procedure is known as angiography.
Angiography is a procedure used in the detection and treatment of abnormalities or restrictions in blood vessels, heart chambers and heart valves. During angiography, a radiographic image of a vascular structure is obtained by injecting radiographic contrast material through a catheter into such a vessel, heart chamber, or heart valve.
X-rays are then passed through the region of the body in which the contrast material was injected. The X-rays are absorbed by the contrast material causing a radiographic outline or image of the blood vessel containing the contrast material. The x-ray images of the blood vessels filled with the contrast material are usually recorded on the film or videotape and displayed on a fluoroscope monitor.
The injection of the contrast or other fluids can be performed either manually or automatically. In both procedures, a catheter is inserted into a vessel, which in turn is connected to a fluid line leading to a manifold and in turn to an injector or syringe.
The plunger of the syringe is then either manually or automatically depressed to inject fluid through the fluid line, the catheter, and into the patient.
In certain situations, it is necessary to dilute the concentration of contrast being injected into a patient. For example, in those patients with renal insufficiency incapable of processing concentrated contrast through their system, or in cases where a large amount of contrast is used, such as complicated coronary interventions (PTCA) or peripheral (PTA) cases with runoffs, direct injections of contrasts, are not possible. Accordingly, it is necessary to mix the contrasts and saline prior to injection to arrive at the appropriate dilution percentage. Such processes are necessarily slow and are currently difficult to achieve.
In addition, during injections, it is desirable for the physician or technician to be provided with feedback as to the pressure within the vessel. This is commonly provided by way of a pressure transducer mounted relatively close to the injection apparatus. However, since a relatively long expanse of conduit exists between the catheter and the injector, typically on the order of four feet or more, pressure waveforms must be transmitted through the fluid contained within that conduit all the way from the body of the patient, through the catheter, and back to the pressure transducer. Due to such distances, the waveforms may be substantially dampened by the time they reach the transducer thereby providing an inaccurate or poor signal for display to the physician.
Furthermore, after an injection is made, and it is desired to remove the contrast from the injection system or change the fluid being injected, it is currently necessary to evacuate or aspirate the entire injection line. It would be advantageous if the waste could be quickly removed, while at the same time limiting the total volume of waste fluid encountered by the system.
SUMMARY OF THE DISCLOSURE
In accordance with one aspect of the disclosure, an injection system is provided which comprises a first power actuated injector, a second power actuated injector, a fitting, and a catheter. The first power actuated injector is adapted to inject a first fluid through a first fluid line having a distal end, and the second power actuated injector is adapted to inject a second fluid through a second fluid line having a distal end. The fitting has first and second inputs and an output, with the distal ends of the first and second fluid lines being connected to the first and second inputs of the fitting, respectively. The catheter is connected to the fitting output.
In accordance with another aspect of the disclosure, a method of injecting fluid is provided which comprises the steps of providing a first power actuated injector, providing a second power actuated injector, connecting first and second fluid lines to a single catheter, and actuating one of the first and second power actuated injectors. The first power actuated injector is adapted to transport a first fluid from a first receptacle through the first fluid line, while the second power actuated injector is adapted to transport a second fluid from a second receptacle through the second fluid line.
These and other aspects and features of the disclosure will become more apparent upon reading the following detailed description in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic representation of an injection system constructed in accordance with the teachings of the disclosure;
FIG. 2 is a schematic representation of an injection system constructed in accordance with the teachings of the disclosure;
FIG. 3 is a schematic representation of an injection system in a first position;
FIG. 4 is a schematic representation of an injection system in a second position;
FIG. 5 is a schematic representation of an injection system in a third position;
FIG. 6 is a schematic representation of an injection system in a fourth position; and FIG. 7 is a schematic representation of an injection system in a fifth position.
While the disclosure is susceptible to various modifications and alternative constructions, certain illustrative embodiments thereof have been shown in the drawings and will be described below in detail. It should be understood, however, that there is no intention to limit the disclosure to the specific forms disclosed, but on the contrary, the intention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the disclosure as defined by the appended claims.
DETAILED DESCRIPTION
Referring now to the drawings, an injection system constructed in accordance with the teachings of the disclosure is generally depicted by reference numeral 20.
While the system 20 is described herein in conjunction with angiographic procedures wherein radiopaque contrast is utilized, it is to be understood that the teachings of the disclosure can be utilized to construct injection systems for any other type of fluid as well. In the paragraphs that follow, the relative positions of the components of the system 20 will be described in terms of being "upstream" or "downstream" from one another. It is to be understood that if two components A and B are provided with component A being closer to a patient, component A is said to be "downstream"
of component B, and component B is said to be "upstream" of component A.
The injection system 20 includes, in the first embodiment of FIG. l, a first injector 22 and a second injector 24 adapted to draw fluid from a first fluid supply 26 and a second fluid supply 28, respectively. In the depicted embodiment, the first fluid supply 26 may be a supply of contrast while the second fluid supply 28 may be a supply of saline. The saline and contrast are directed by the first and second injectors 22, 24 through first and second fluid lines 30 and 32, respectively. A bubble detector 33 may be provided to detect and/or remove gas entrained in the liquid of supplies 26 I 5 and 28. As used herein, solid lines are provided in the figures to illustrate fluid connections, while dashed lines are used to illustrate electrical connections.
The first and second fluid lines 30, 32 include distal ends 34, 36, respectively, which may terminate at first and second inputs 38, 40, respectively, of a Y-shaped fitting 42. The Y-shaped fitting 42 further includes an outlet 44 connected to an output conduit 46. An advantage of using such a fitting having multiple inlets and one outlet is that multiple fluids can be supplied under pressure from multiple sources and be mixed in the fitting 42 prior to injection. Accordingly, the injected fluid can be tailored in terms of viscosity, concentration, etc., during the procedure without requiring pre-mixing of same as is required by the prior art. Control valves 48 and 50 may be provided within the first and second fluid lines 30, 32, respectively.
It is to be understood that the fitting 42 need not be Y-shaped, and that in alternative embodiments may be T-shaped, or otherwise shaped to allow coupling of fluid lines as would be contemplated by one skilled in the art. Moreover, the control valves 48 and 50 may be provided in a variety of forms such as, but not limited to, check valves, pinch valves, or any other type of valve contemplated by one skilled in the art.
The output conduit 46 terminates at a valve 52 having first and second inputs 54, 56 and an output 58. The input 54 is connected to the output conduit 46.
The input 56 is connected to a medication supply 59. The output 58 is connected to a conduit 60 which leads to a medical device 62 which may be a catheter, or the like.
Also depicted in FIG. 1 is a waste line 64 having an input 66 connected to the output conduit 46, and an output 68 connected to a waste receptacle 70. A pump 72 is operatively associated with the waste line 64 to draw fluid from the output conduit 46 and any fluid lines fluidically connected to the output conduit 46. It can therefore be seen that separate lines 30, 32 and 64 are supplied for the contrast, saline, and waste, respectively. This is advantageous in that when it is desired, for example, to inject saline after injecting contrast, and injection can occur immediately without first clearing the system of contrast from the prior injection. This is in direct opposition to the prior art wherein the contrast existing in the line (e. g., 4-5 ccs of fluid) would have to first be injected into the patient, or cleaned, prior to saline injection.
Moreover, by providing the waste line 64 close to the medical device 62, when the device 62 is to be drained of waste, it can be done quickly and with far less waste.
FIG. 1 is a schematic representation of an injection system constructed in accordance with the teachings of the disclosure;
FIG. 2 is a schematic representation of an injection system constructed in accordance with the teachings of the disclosure;
FIG. 3 is a schematic representation of an injection system in a first position;
FIG. 4 is a schematic representation of an injection system in a second position;
FIG. 5 is a schematic representation of an injection system in a third position;
FIG. 6 is a schematic representation of an injection system in a fourth position; and FIG. 7 is a schematic representation of an injection system in a fifth position.
While the disclosure is susceptible to various modifications and alternative constructions, certain illustrative embodiments thereof have been shown in the drawings and will be described below in detail. It should be understood, however, that there is no intention to limit the disclosure to the specific forms disclosed, but on the contrary, the intention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the disclosure as defined by the appended claims.
DETAILED DESCRIPTION
Referring now to the drawings, an injection system constructed in accordance with the teachings of the disclosure is generally depicted by reference numeral 20.
While the system 20 is described herein in conjunction with angiographic procedures wherein radiopaque contrast is utilized, it is to be understood that the teachings of the disclosure can be utilized to construct injection systems for any other type of fluid as well. In the paragraphs that follow, the relative positions of the components of the system 20 will be described in terms of being "upstream" or "downstream" from one another. It is to be understood that if two components A and B are provided with component A being closer to a patient, component A is said to be "downstream"
of component B, and component B is said to be "upstream" of component A.
The injection system 20 includes, in the first embodiment of FIG. l, a first injector 22 and a second injector 24 adapted to draw fluid from a first fluid supply 26 and a second fluid supply 28, respectively. In the depicted embodiment, the first fluid supply 26 may be a supply of contrast while the second fluid supply 28 may be a supply of saline. The saline and contrast are directed by the first and second injectors 22, 24 through first and second fluid lines 30 and 32, respectively. A bubble detector 33 may be provided to detect and/or remove gas entrained in the liquid of supplies 26 I 5 and 28. As used herein, solid lines are provided in the figures to illustrate fluid connections, while dashed lines are used to illustrate electrical connections.
The first and second fluid lines 30, 32 include distal ends 34, 36, respectively, which may terminate at first and second inputs 38, 40, respectively, of a Y-shaped fitting 42. The Y-shaped fitting 42 further includes an outlet 44 connected to an output conduit 46. An advantage of using such a fitting having multiple inlets and one outlet is that multiple fluids can be supplied under pressure from multiple sources and be mixed in the fitting 42 prior to injection. Accordingly, the injected fluid can be tailored in terms of viscosity, concentration, etc., during the procedure without requiring pre-mixing of same as is required by the prior art. Control valves 48 and 50 may be provided within the first and second fluid lines 30, 32, respectively.
It is to be understood that the fitting 42 need not be Y-shaped, and that in alternative embodiments may be T-shaped, or otherwise shaped to allow coupling of fluid lines as would be contemplated by one skilled in the art. Moreover, the control valves 48 and 50 may be provided in a variety of forms such as, but not limited to, check valves, pinch valves, or any other type of valve contemplated by one skilled in the art.
The output conduit 46 terminates at a valve 52 having first and second inputs 54, 56 and an output 58. The input 54 is connected to the output conduit 46.
The input 56 is connected to a medication supply 59. The output 58 is connected to a conduit 60 which leads to a medical device 62 which may be a catheter, or the like.
Also depicted in FIG. 1 is a waste line 64 having an input 66 connected to the output conduit 46, and an output 68 connected to a waste receptacle 70. A pump 72 is operatively associated with the waste line 64 to draw fluid from the output conduit 46 and any fluid lines fluidically connected to the output conduit 46. It can therefore be seen that separate lines 30, 32 and 64 are supplied for the contrast, saline, and waste, respectively. This is advantageous in that when it is desired, for example, to inject saline after injecting contrast, and injection can occur immediately without first clearing the system of contrast from the prior injection. This is in direct opposition to the prior art wherein the contrast existing in the line (e. g., 4-5 ccs of fluid) would have to first be injected into the patient, or cleaned, prior to saline injection.
Moreover, by providing the waste line 64 close to the medical device 62, when the device 62 is to be drained of waste, it can be done quickly and with far less waste.
Put another way, since prior art systems drain the device using a pump (run in reverse) mounted back by the injector, not only must the device be drained with prior art systems, but the entire line connecting the injector to the device must be drained as well, which is overcome by the present disclosure. This represents not only a large volume (e. g., 4-5 ccs) of waste, but a source of delay as well.
A pressure sensor 74 may be positioned proximate the catheter 62. The pressure sensor 74 is shown connected to the catheter conduit 60. An advantage of positioning the pressure transducer 74 close to~the catheter 62 is that, unlike prior art systems, the pressure waveforms need not be communicated all the way down the line to the injector and thus be subjected to substantial waveform dampening, but rather can be monitored before such dampening can occur and thus result in a much more accurate signal. The pressure sensor 74 generates a signal 76 representative of fluid pressure within the output conduit 46. The signal 76 is communicated to a controller 78 which in tum generates a display signal 78 for transmission to an operator interface module 79, enabling the physician or technician to monitor pressure.
In alternative embodiments, the pressure signal 76 may be used by the controller 78 in determining or modifying control signals 80, 82 for controlling actuators 84 and 86 connected to the first and second injectors 22 and 24, respectively. The actuators 84 and 86 may be any suitable actuating device such as, but not limited to, motor driven, hydraulically powered, or pneumatically powered plungers. However, it is to be understood that the control signals 80, 82 are primarily generated by the operator depressing or otherwise actuating buttons, keypads, or the like for varying the ratio of a first fluid (e. g., contrast) to a second fluid (e. g., saline), _7_ and that the pressure signal 76 is provided mainly to enable the physician to monitor pressure.
The operator interface module 88 is associated with the controller 78 to enable a user to affect operation of the system 20 and provide the user with valuable feedback as to the operation of the system 20. For example, the operator interface module 88 may include a display screen such as a glass plasma, liquid crystal, or cathode ray tube display, or the like, and/or a plurality of input/output devices such as the aforementioned keypad, buttons, mouse or-the like for entering and receiving data.
The controller may be electrically connected to valves 48, 50, 90, 92, 94, and 96 to monitor the valves, or control movement of fluid flow directions.
In operation, the system 20 is able to inject fluid or fluids through the catheter 62 and into a patient (not shown). By employing the first and second injectors 22 and 24, first and second fluids, such as saline and contrast, can be sequentially injected with substantially no down time for the system 20. In addition, the saline and contrast can be simultaneously injected by simultaneously operating the first and second injectors 22. This in turn forces saline and contrast into the fitting 42 and automatically mixes the fluids. Moreover, as opposed to existing systems which employ a single injector for contrast and a peristaltic pump for saline/flushing, the separate injector dedicated to saline injection enables smooth flow without the pulsating flow associated with peristaltic pumps.
When the system is to be drained, the separate waste line 64 can be utilized along with pump 72 to quickly and efficiently draw fluid out of the system 20 and ready the system 24 for additional injections. By providing the pressure sensor 74 _g_ proximate the catheter 62, the signal 76 representative of fluid pressure within the catheter conduit 60 is more accurate and less susceptible to wave dampening.
Referring now to FIG. 2, an alternative embodiment of an injection system is generally referred to by reference numeral 100. Wherein like elements are utilized, like reference numerals are employed. A difference in the alternative embodiment is that only a single injector 22 is employed. More specifically, the injector 22 is used to inject contrast, in the depicted embodiment, while the saline is injected by the peristaltic pump 72 run in reverse.
FIG. 2 also depicts a possible position of the injector 22 and actuator 84 relative to an operating table 102. As shown therein, the injector 22 and actuator may be proximate the table 102, i.e., on an underside 104 thereof. In so doing, the system 100 is made more efficient in that the supply lines of the system 100 can be made shorter, thereby reducing the amount of contrast or other fluid needed in the system.
Such placement of the injector and other equipment of the system can be employed 1 S with the first embodiment with equal efficacy.
With regard to the actual valves used to control fluid flow through the various fluid lines, any number of valve types, including but not limited to check valves, high pressure valves, rotary manifold valves, pinch valves and the like could be employed.
In the embodiment of FIGS. 3-7, a pinch valve system is disclosed. FIGS. 3-7 also depict one potential type of user control incorporated within the operator interface 88.
Beginning with FIG. 3, it will be noted that each valve is depicted as a pinch valve, meaning the valve includes an anvil 110, and a movable wedge 112 adapted to move toward and away from the anvil 110 as by a pneumatic/hydraulic cylinder, motor, or the like to pinch a flexible tube (forming the fluid line) therebetween and this present fluid flow. It is to be understood that other types of pinch valves, such as those employing multiple movable elements adapted to move toward one another, are possible. For example, in FIG. 3, the contrast valve 96 is depicted in an open position, with the waste valve 92, saline valve 94, and an output valve 116 shown closed. The pressure valve 90, as described herein, is always open except during inj ection (FIG. 4) to provide the user with a constant pressure reading.
With the contrast valve 96 open, the injector 22 can retract, thereby drawing contrast from supply 26, through the valve 96 and into the injector 22. The user can then adjust a control unit 120 of the operator interface 88 to specify injection as shown in FIG. 4, whereupon the contrast valve 96 is closed and the output valve 116 is opened. The injector plunger (not shown) can then advance, thereby pushing contrast from the injector 22 to the catheter 62 and patient.
FIGS. S-7 are much the same, but with the control unit 120 moved to positions 1 S corresponding to saline, waste, and pressure, respectively, with the corresponding valve (94, 92, 90) being depicted in an open position when selected with the control unit 120. It is to be understood that the control unit 120 need not be provided by way of the rotary knob depicted but could be any other suitable mechanism enabling a setting to be selected and a corresponding valve signal to be generated. This may include, but not be limited to push buttons and toggle switches, or non-handheld units such as monitor touch screens, and the like. The valve signal generated could be used to actuate a motor (not shown) for moving the wedge 112, energizing a solenoid, pressurizing a hydraulic or pneumatic cylinder, releasing a spring, or the like.
Moreover, the signal could be used to manipulate the valve such that vacuum pressure created by the retracting plunger of the injector 22 could cause the desired valve to open. For example, the valves could be provided as normally closed valves wherein the actuation of a solenoid holds the valve open. The control signal could actuate the solenoid so as to release the valve, allowing only a spring or the like to hold the valve closed. The spring could be sized such that the vacuum pressure created by the retracting injector plunger could overcome the spring force and thereby open the valve. Other systems are certainly possible.
From the foregoing, one of ordinary skill in the art will appreciate that the present disclosure sets forth an apparatus and method for managing fluids injected and otherwise used in a medical procedure.
A pressure sensor 74 may be positioned proximate the catheter 62. The pressure sensor 74 is shown connected to the catheter conduit 60. An advantage of positioning the pressure transducer 74 close to~the catheter 62 is that, unlike prior art systems, the pressure waveforms need not be communicated all the way down the line to the injector and thus be subjected to substantial waveform dampening, but rather can be monitored before such dampening can occur and thus result in a much more accurate signal. The pressure sensor 74 generates a signal 76 representative of fluid pressure within the output conduit 46. The signal 76 is communicated to a controller 78 which in tum generates a display signal 78 for transmission to an operator interface module 79, enabling the physician or technician to monitor pressure.
In alternative embodiments, the pressure signal 76 may be used by the controller 78 in determining or modifying control signals 80, 82 for controlling actuators 84 and 86 connected to the first and second injectors 22 and 24, respectively. The actuators 84 and 86 may be any suitable actuating device such as, but not limited to, motor driven, hydraulically powered, or pneumatically powered plungers. However, it is to be understood that the control signals 80, 82 are primarily generated by the operator depressing or otherwise actuating buttons, keypads, or the like for varying the ratio of a first fluid (e. g., contrast) to a second fluid (e. g., saline), _7_ and that the pressure signal 76 is provided mainly to enable the physician to monitor pressure.
The operator interface module 88 is associated with the controller 78 to enable a user to affect operation of the system 20 and provide the user with valuable feedback as to the operation of the system 20. For example, the operator interface module 88 may include a display screen such as a glass plasma, liquid crystal, or cathode ray tube display, or the like, and/or a plurality of input/output devices such as the aforementioned keypad, buttons, mouse or-the like for entering and receiving data.
The controller may be electrically connected to valves 48, 50, 90, 92, 94, and 96 to monitor the valves, or control movement of fluid flow directions.
In operation, the system 20 is able to inject fluid or fluids through the catheter 62 and into a patient (not shown). By employing the first and second injectors 22 and 24, first and second fluids, such as saline and contrast, can be sequentially injected with substantially no down time for the system 20. In addition, the saline and contrast can be simultaneously injected by simultaneously operating the first and second injectors 22. This in turn forces saline and contrast into the fitting 42 and automatically mixes the fluids. Moreover, as opposed to existing systems which employ a single injector for contrast and a peristaltic pump for saline/flushing, the separate injector dedicated to saline injection enables smooth flow without the pulsating flow associated with peristaltic pumps.
When the system is to be drained, the separate waste line 64 can be utilized along with pump 72 to quickly and efficiently draw fluid out of the system 20 and ready the system 24 for additional injections. By providing the pressure sensor 74 _g_ proximate the catheter 62, the signal 76 representative of fluid pressure within the catheter conduit 60 is more accurate and less susceptible to wave dampening.
Referring now to FIG. 2, an alternative embodiment of an injection system is generally referred to by reference numeral 100. Wherein like elements are utilized, like reference numerals are employed. A difference in the alternative embodiment is that only a single injector 22 is employed. More specifically, the injector 22 is used to inject contrast, in the depicted embodiment, while the saline is injected by the peristaltic pump 72 run in reverse.
FIG. 2 also depicts a possible position of the injector 22 and actuator 84 relative to an operating table 102. As shown therein, the injector 22 and actuator may be proximate the table 102, i.e., on an underside 104 thereof. In so doing, the system 100 is made more efficient in that the supply lines of the system 100 can be made shorter, thereby reducing the amount of contrast or other fluid needed in the system.
Such placement of the injector and other equipment of the system can be employed 1 S with the first embodiment with equal efficacy.
With regard to the actual valves used to control fluid flow through the various fluid lines, any number of valve types, including but not limited to check valves, high pressure valves, rotary manifold valves, pinch valves and the like could be employed.
In the embodiment of FIGS. 3-7, a pinch valve system is disclosed. FIGS. 3-7 also depict one potential type of user control incorporated within the operator interface 88.
Beginning with FIG. 3, it will be noted that each valve is depicted as a pinch valve, meaning the valve includes an anvil 110, and a movable wedge 112 adapted to move toward and away from the anvil 110 as by a pneumatic/hydraulic cylinder, motor, or the like to pinch a flexible tube (forming the fluid line) therebetween and this present fluid flow. It is to be understood that other types of pinch valves, such as those employing multiple movable elements adapted to move toward one another, are possible. For example, in FIG. 3, the contrast valve 96 is depicted in an open position, with the waste valve 92, saline valve 94, and an output valve 116 shown closed. The pressure valve 90, as described herein, is always open except during inj ection (FIG. 4) to provide the user with a constant pressure reading.
With the contrast valve 96 open, the injector 22 can retract, thereby drawing contrast from supply 26, through the valve 96 and into the injector 22. The user can then adjust a control unit 120 of the operator interface 88 to specify injection as shown in FIG. 4, whereupon the contrast valve 96 is closed and the output valve 116 is opened. The injector plunger (not shown) can then advance, thereby pushing contrast from the injector 22 to the catheter 62 and patient.
FIGS. S-7 are much the same, but with the control unit 120 moved to positions 1 S corresponding to saline, waste, and pressure, respectively, with the corresponding valve (94, 92, 90) being depicted in an open position when selected with the control unit 120. It is to be understood that the control unit 120 need not be provided by way of the rotary knob depicted but could be any other suitable mechanism enabling a setting to be selected and a corresponding valve signal to be generated. This may include, but not be limited to push buttons and toggle switches, or non-handheld units such as monitor touch screens, and the like. The valve signal generated could be used to actuate a motor (not shown) for moving the wedge 112, energizing a solenoid, pressurizing a hydraulic or pneumatic cylinder, releasing a spring, or the like.
Moreover, the signal could be used to manipulate the valve such that vacuum pressure created by the retracting plunger of the injector 22 could cause the desired valve to open. For example, the valves could be provided as normally closed valves wherein the actuation of a solenoid holds the valve open. The control signal could actuate the solenoid so as to release the valve, allowing only a spring or the like to hold the valve closed. The spring could be sized such that the vacuum pressure created by the retracting injector plunger could overcome the spring force and thereby open the valve. Other systems are certainly possible.
From the foregoing, one of ordinary skill in the art will appreciate that the present disclosure sets forth an apparatus and method for managing fluids injected and otherwise used in a medical procedure.
Claims (12)
1. An injection system, comprising:
a first power-actuated injector adapted to inject a first fluid through a first fluid line having a distal end;
a second power-actuated injector adapted to inject a second fluid through a second fluid line having a distal end;
a fitting having first and second inputs and an output, the distal ends of the first and second fluid lines being connected to the first and second inputs of the fitting, respectively;
a medical device connected to the fitting output through a third fluid line;
and a pressure sensor connected to the third fluid line at downstream of the fitting and adapted to generate a signal representative of fluid pressure within the medical device.
a first power-actuated injector adapted to inject a first fluid through a first fluid line having a distal end;
a second power-actuated injector adapted to inject a second fluid through a second fluid line having a distal end;
a fitting having first and second inputs and an output, the distal ends of the first and second fluid lines being connected to the first and second inputs of the fitting, respectively;
a medical device connected to the fitting output through a third fluid line;
and a pressure sensor connected to the third fluid line at downstream of the fitting and adapted to generate a signal representative of fluid pressure within the medical device.
2. The injection system of claim 1, wherein the medical device is a catheter.
3. The injection system of claim 1, wherein the first fluid is contrast and the second fluid is saline.
4. The injector system of claim 1, wherein the fining is Y-shaped.
5. The injection system of claim 1, further including a waste line having a proximal end and a distal end, the distal end being connected to the third fluid line downstream of the fitting.
6. The injection system of claim 5, further including a waste receptacle connected to the distal end of the waste line and a pump operatively associated with the waste line.
7. The injection system of claim 6, further including a valve downstream of the distal end of the waste line.
8. The injection system of claim 1, wherein the pressure sensor is connected to the third fluid line upstream of the medical device.
9. The injection system of claim 7, further including a medication in communication with the valve.
10. The injection system of claim 1, further including:
a catheter connected to the output of the fitting;
a waste line and a pump operatively associated with the waste line, the waste line having an input in fluid communication with the fitting; and a controller adapted to receive signals and generate control signals for actuation injectors; wherein the pressure sensor is proximate to the catheter.
a catheter connected to the output of the fitting;
a waste line and a pump operatively associated with the waste line, the waste line having an input in fluid communication with the fitting; and a controller adapted to receive signals and generate control signals for actuation injectors; wherein the pressure sensor is proximate to the catheter.
11. The injection system of claim 10, further including a source of medication in fluid communication with the catheter.
12. The injection system of claim 10, further including:
a source of contrast in fluid communication with the first power-actuated injector;
and a source of saline in fluid communication with the second power-actuated injector.
a source of contrast in fluid communication with the first power-actuated injector;
and a source of saline in fluid communication with the second power-actuated injector.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/193,376 US7267667B2 (en) | 2002-07-11 | 2002-07-11 | Fluid management system for coronary intervention |
US10/193,376 | 2002-07-11 | ||
PCT/US2003/021248 WO2004006994A1 (en) | 2002-07-11 | 2003-07-08 | Fluid management system for coronary intervention |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2487496A1 CA2487496A1 (en) | 2004-01-22 |
CA2487496C true CA2487496C (en) | 2011-08-30 |
Family
ID=30114504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2487496A Expired - Lifetime CA2487496C (en) | 2002-07-11 | 2003-07-08 | Fluid management system for coronary intervention |
Country Status (8)
Country | Link |
---|---|
US (1) | US7267667B2 (en) |
EP (1) | EP1521606B1 (en) |
JP (1) | JP4663320B2 (en) |
AT (1) | ATE458513T1 (en) |
AU (1) | AU2003261125A1 (en) |
CA (1) | CA2487496C (en) |
DE (1) | DE60331433D1 (en) |
WO (1) | WO2004006994A1 (en) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7094216B2 (en) | 2000-10-18 | 2006-08-22 | Medrad, Inc. | Injection system having a pressure isolation mechanism and/or a handheld controller |
US7455666B2 (en) | 2001-07-13 | 2008-11-25 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
US20080154214A1 (en) | 2006-12-22 | 2008-06-26 | Medrad, Inc. | Flow Based Pressure Isolation and Fluid Delivery System Including Flow Based Pressure Isolation |
JP2004065737A (en) * | 2002-08-08 | 2004-03-04 | Nemoto Kyorindo:Kk | Liquid chemical injecting apparatus |
US9956377B2 (en) | 2002-09-20 | 2018-05-01 | Angiodynamics, Inc. | Method and apparatus for intra-aortic substance delivery to a branch vessel |
US7771389B2 (en) * | 2004-02-17 | 2010-08-10 | Mallinckrodt Inc. | Injector auto purge |
EP1758501A1 (en) * | 2004-05-26 | 2007-03-07 | Martil Instruments B.V. | Catheter and portable data managing device assembly |
US7393181B2 (en) | 2004-09-17 | 2008-07-01 | The Penn State Research Foundation | Expandable impeller pump |
EP1812101A4 (en) | 2004-11-16 | 2014-04-23 | Medrad Inc | Modeling of pharmaceutical propagation |
HUE034171T2 (en) * | 2004-11-24 | 2018-02-28 | Bayer Healthcare Llc | Devices, systems and methods for fluid delivery |
US7766883B2 (en) | 2007-10-30 | 2010-08-03 | Medrad, Inc. | System and method for proportional mixing and continuous delivery of fluids |
US9011377B2 (en) | 2008-11-05 | 2015-04-21 | Bayer Medical Care Inc. | Fluid mixing control device for a multi-fluid delivery system |
US9433730B2 (en) | 2013-03-14 | 2016-09-06 | Bayer Healthcare Llc | Fluid mixing control device for a multi-fluid delivery system |
CN103550836B (en) | 2005-11-21 | 2018-02-06 | 阿西斯特医疗系统有限公司 | Medical fluid injection system |
CN102380135A (en) | 2006-03-23 | 2012-03-21 | 宾州研究基金会 | Heart assist device with expandable impeller pump |
EP1867356A1 (en) * | 2006-06-16 | 2007-12-19 | Swiss Medical Care | System for the injection of contrast agents |
EP2078536A4 (en) * | 2006-10-18 | 2015-02-18 | Terumo Corp | Medical apparatus |
DK2097835T3 (en) | 2006-12-29 | 2018-09-03 | Bayer Healthcare Llc | PATIENT-BASED PARAMETER GENERATION SYSTEMS FOR MEDICAL INJECTION PROCEDURES |
EP3308812A3 (en) * | 2007-02-26 | 2018-07-04 | CareFusion 303, Inc. | Automatic relay pump system |
CN103976736B (en) | 2007-07-17 | 2017-01-11 | 拜耳医药保健有限责任公司 | Devices and systems for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery |
WO2009041004A1 (en) * | 2007-09-27 | 2009-04-02 | Nemoto Kyorindo Co., Ltd. | Chemical dosing device, radiographic system and computer program |
US8608484B2 (en) | 2008-03-04 | 2013-12-17 | Medrad, Inc. | Dynamic anthropomorphic cardiovascular phantom |
US8315449B2 (en) | 2008-06-24 | 2012-11-20 | Medrad, Inc. | Identification of regions of interest and extraction of time value curves in imaging procedures |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
US7922700B2 (en) * | 2008-10-30 | 2011-04-12 | Acist Medical Systems, Inc. | Pinch valve mechanism for a medical fluid injection device |
US9421330B2 (en) | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
ES2629012T3 (en) | 2009-07-24 | 2017-08-07 | Bayer Healthcare Llc | Multifluid medical injection system |
EP2298382A1 (en) | 2009-09-18 | 2011-03-23 | SMC-Swiss Medical Care S.A. | Device for injecting contrast products |
US20110092955A1 (en) | 2009-10-07 | 2011-04-21 | Purdy Phillip D | Pressure-Sensing Medical Devices, Systems and Methods, and Methods of Forming Medical Devices |
RU2016138172A (en) | 2010-06-24 | 2018-12-12 | Байер Медикэл Кер Инк. | MODELING THE DISTRIBUTION OF A PHARMACEUTICAL PRODUCT AND GENERATION OF PARAMETERS FOR INJECTION PROTOCOLS |
WO2012094641A2 (en) | 2011-01-06 | 2012-07-12 | Thoratec Corporation | Percutaneous heart pump |
US20130123619A1 (en) * | 2011-05-04 | 2013-05-16 | Acist Medical Systems, Inc. | Hemodynamic pressure sensor test system and method |
RU2605272C2 (en) | 2012-05-14 | 2016-12-20 | БАЙЕР ХелсКер ЛЛСи | Systems and methods of determining protocols of injection of pharmaceutical fluid on the basis of voltage on x-ray tube |
US9327067B2 (en) | 2012-05-14 | 2016-05-03 | Thoratec Corporation | Impeller for catheter pump |
US9872947B2 (en) | 2012-05-14 | 2018-01-23 | Tc1 Llc | Sheath system for catheter pump |
US8721517B2 (en) | 2012-05-14 | 2014-05-13 | Thoratec Corporation | Impeller for catheter pump |
US9446179B2 (en) | 2012-05-14 | 2016-09-20 | Thoratec Corporation | Distal bearing support |
DE102013008168A1 (en) | 2012-05-14 | 2013-11-14 | Thoratec Corporation | Impeller for catheter pump |
US9421311B2 (en) | 2012-07-03 | 2016-08-23 | Thoratec Corporation | Motor assembly for catheter pump |
US9358329B2 (en) | 2012-07-03 | 2016-06-07 | Thoratec Corporation | Catheter pump |
EP4186557A1 (en) | 2012-07-03 | 2023-05-31 | Tc1 Llc | Motor assembly for catheter pump |
US9241641B2 (en) | 2012-07-20 | 2016-01-26 | Acist Medical Systems, Inc. | Fiber optic sensor assembly for sensor delivery device |
US10279112B2 (en) * | 2012-09-24 | 2019-05-07 | Angiodynamics, Inc. | Power injector device and method of use |
US11369739B2 (en) * | 2013-01-21 | 2022-06-28 | Medline Industries, Lp | Method to provide injection system parameters for injecting fluid into patient |
US11077294B2 (en) | 2013-03-13 | 2021-08-03 | Tc1 Llc | Sheath assembly for catheter pump |
WO2014164136A1 (en) | 2013-03-13 | 2014-10-09 | Thoratec Corporation | Fluid handling system |
US9555379B2 (en) | 2013-03-13 | 2017-01-31 | Bayer Healthcare Llc | Fluid path set with turbulent mixing chamber, backflow compensator |
US11033728B2 (en) | 2013-03-13 | 2021-06-15 | Tc1 Llc | Fluid handling system |
EP3797810A1 (en) | 2013-03-15 | 2021-03-31 | Tc1 Llc | Catheter pump assembly including a stator |
US9308302B2 (en) | 2013-03-15 | 2016-04-12 | Thoratec Corporation | Catheter pump assembly including a stator |
CN105916542B (en) | 2014-02-18 | 2020-01-14 | 拜耳医药保健有限公司 | Multi-dose disposable system |
US10583232B2 (en) | 2014-04-15 | 2020-03-10 | Tc1 Llc | Catheter pump with off-set motor position |
EP3131615B1 (en) | 2014-04-15 | 2021-06-09 | Tc1 Llc | Sensors for catheter pumps |
WO2015160990A1 (en) | 2014-04-15 | 2015-10-22 | Thoratec Corporation | Catheter pump introducer systems and methods |
EP3479854A1 (en) | 2014-04-15 | 2019-05-08 | Tc1 Llc | Catheter pump with access ports |
US10449279B2 (en) | 2014-08-18 | 2019-10-22 | Tc1 Llc | Guide features for percutaneous catheter pump |
WO2016118784A1 (en) | 2015-01-22 | 2016-07-28 | Thoratec Corporation | Attachment mechanisms for motor of catheter pump |
EP3247420B1 (en) | 2015-01-22 | 2019-10-02 | Tc1 Llc | Reduced rotational mass motor assembly for catheter pump |
WO2016118781A2 (en) | 2015-01-22 | 2016-07-28 | Thoratec Corporation | Motor assembly with heat exchanger for catheter pump |
US9907890B2 (en) | 2015-04-16 | 2018-03-06 | Tc1 Llc | Catheter pump with positioning brace |
EP3423130A1 (en) | 2016-03-03 | 2019-01-09 | Bayer Healthcare LLC | System and method for improved fluid delivery in multi-fluid injector systems |
US11491322B2 (en) | 2016-07-21 | 2022-11-08 | Tc1 Llc | Gas-filled chamber for catheter pump motor assembly |
EP3487549B1 (en) | 2016-07-21 | 2021-02-24 | Tc1 Llc | Fluid seals for catheter pump motor assembly |
US11607489B2 (en) | 2017-05-26 | 2023-03-21 | Bayer Healthcare Llc | Injector state logic with hemodynamic monitoring |
US11779702B2 (en) | 2017-08-31 | 2023-10-10 | Bayer Healthcare Llc | Method for dynamic pressure control in a fluid injector system |
JP7221885B2 (en) | 2017-08-31 | 2023-02-14 | バイエル・ヘルスケア・エルエルシー | Injector pressure calibration system and method |
WO2019046261A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | System and method for drive member position and fluid injector system mechanical calibration |
US11478581B2 (en) | 2017-08-31 | 2022-10-25 | Bayer Healthcare Llc | Fluid injector system volume compensation system and method |
CA3068739A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | Fluid path impedance assessment for improving fluid delivery performance |
JP7404360B2 (en) | 2018-10-31 | 2023-12-25 | アシスト・メディカル・システムズ,インコーポレイテッド | fluid pressure sensor protection |
EP3831424A1 (en) * | 2019-12-02 | 2021-06-09 | Siemens Healthcare GmbH | Controller for a contrast media power injector |
WO2021214838A1 (en) * | 2020-04-20 | 2021-10-28 | 株式会社エスケーエレクトロニクス | Pressurization-type drug injector having drug exposure preventive function |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3888239A (en) * | 1974-06-21 | 1975-06-10 | Morton K Rubinstein | Fluid injection system |
DE4121568C2 (en) * | 1991-04-22 | 1997-07-03 | Schering Ag | Method and device for producing a contrast medium from a concentrate |
US5450847A (en) | 1991-04-22 | 1995-09-19 | Schering Aktiengesellschaft | Process for making doses formulation of contrast media from concentrate |
EP0650739B1 (en) | 1993-10-28 | 2003-02-26 | Medrad, Inc. | Total system for contrast delivery |
US6099502A (en) | 1995-04-20 | 2000-08-08 | Acist Medical Systems, Inc. | Dual port syringe |
US6221045B1 (en) * | 1995-04-20 | 2001-04-24 | Acist Medical Systems, Inc. | Angiographic injector system with automatic high/low pressure switching |
DE19859811C2 (en) | 1998-12-23 | 2001-05-10 | Hilekes Guido | Contrast agent injection system |
JP4293689B2 (en) | 1999-10-05 | 2009-07-08 | 株式会社根本杏林堂 | Contrast medium injection device |
US6471674B1 (en) * | 2000-04-21 | 2002-10-29 | Medrad, Inc. | Fluid delivery systems, injector systems and methods of fluid delivery |
-
2002
- 2002-07-11 US US10/193,376 patent/US7267667B2/en active Active
-
2003
- 2003-07-08 DE DE60331433T patent/DE60331433D1/en not_active Expired - Fee Related
- 2003-07-08 JP JP2004521549A patent/JP4663320B2/en not_active Expired - Lifetime
- 2003-07-08 AT AT03764370T patent/ATE458513T1/en not_active IP Right Cessation
- 2003-07-08 EP EP03764370A patent/EP1521606B1/en not_active Expired - Lifetime
- 2003-07-08 WO PCT/US2003/021248 patent/WO2004006994A1/en active Application Filing
- 2003-07-08 AU AU2003261125A patent/AU2003261125A1/en not_active Abandoned
- 2003-07-08 CA CA2487496A patent/CA2487496C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1521606A1 (en) | 2005-04-13 |
US7267667B2 (en) | 2007-09-11 |
ATE458513T1 (en) | 2010-03-15 |
CA2487496A1 (en) | 2004-01-22 |
DE60331433D1 (en) | 2010-04-08 |
EP1521606B1 (en) | 2010-02-24 |
JP2005532140A (en) | 2005-10-27 |
AU2003261125A1 (en) | 2004-02-02 |
WO2004006994A1 (en) | 2004-01-22 |
US20040010229A1 (en) | 2004-01-15 |
JP4663320B2 (en) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2487496C (en) | Fluid management system for coronary intervention | |
US9764081B2 (en) | Fluid path containing a pressure isolation valve | |
RU2609808C2 (en) | Injection system of medical liquids | |
US8192397B2 (en) | Medical fluid injection and inflation system | |
US5800397A (en) | Angiographic system with automatic high/low pressure switching | |
US5573515A (en) | Self purging angiographic injector | |
US5882343A (en) | Dual port syringe | |
EP0821600B1 (en) | Self-purging angiographic injector | |
JP5695907B2 (en) | Power injector with patency check using pressure monitoring | |
RU2603823C2 (en) | Apparatus and method to determine contrast media injection parameters to control signal intensity during magnetic resonance angiography | |
WO2005110007A2 (en) | Fluid delivery systems, pressure isolation mechanisms, injector control mechanisms, and methods of use thereof | |
JP2007222656A (en) | Fluid delivery system, pressure isolation mechanism, injector control mechanism, and method of using them | |
CA2725252A1 (en) | Power injector with keep vein open functionality | |
GOLDSTEIN et al. | A novel automated injection system for angiography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20230710 |